Preliminary Experience with Cangrelor for Endovascular Treatment of Challenging Intracranial Aneurysms

ConclusionCangrelor is a  new antiplatelet therapy with a P2Y12 inhibiting effect, with a rapid onset and offset of action, owing to its short half-life. This cases series presents a pilot experience with promising results in terms of antiplatelet management for challenging intracranial aneurysms treated by stent assist ed coiling or flow-diverter stents.
Source: Klinische Neuroradiologie - Category: Radiology Source Type: research